Published in Cancer Weekly, February 14th, 2012
According to Jeff Jacob, CEO of Cancer Prevention Pharmaceuticals, Inc. and a C-Path board member who headed the CEO search process, "With the creation of C-Path as a public/private partnership model, Dr. Woosley forever changed the way scientists share information and navigate the drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.